» Articles » PMID: 10544198

Inhibition of Interleukin 2 Signaling and Signal Transducer and Activator of Transcription (STAT)5 Activation During T Cell Receptor-mediated Feedback Inhibition of T Cell Expansion

Overview
Journal J Exp Med
Date 1999 Nov 2
PMID 10544198
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Limitation of clonal expansion of activated T cells is necessary for immune homeostasis, and is achieved by growth arrest and apoptosis. Growth arrest and apoptosis can occur passively secondary to cytokine withdrawal, or can be actively induced by religation of the T cell receptor (TCR) in previously activated proliferating T cells. TCR-induced apoptosis appears to require prior growth arrest, and is mediated by death receptors such as Fas. We tested whether TCR religation affects T cell responses to interleukin (IL)-2, a major T cell growth and survival factor. TCR ligation in activated primary human T cells blocked IL-2 induction of signal transducer and activator of transcription (STAT)5 DNA binding, phosphorylation of STAT5, Janus kinase (Jak)1, Jak3, and Akt, and kinase activity of Jak1 and Jak3. Inhibition was mediated by the mitogen-activated protein kinase kinase (MEK)-extracellular stimulus-regulated kinase (ERK) signaling pathway, similar to the mechanism of inhibition of IL-6 signaling we have described previously. TCR ligation blocked IL-2 activation of genes and cell cycle regulatory proteins, and suppressed cell proliferation and expansion. These results identify TCR-induced inhibition of IL-2 signaling as a novel mechanism that underlies antigen-mediated feedback limitation of T cell expansion, and suggest that modulation of cytokine activity by antigen receptor signals plays an important role in the regulation of lymphocyte function.

Citing Articles

Differential contribution for ERK1 and ERK2 kinases in BRAF-triggered phenotypes in adult mouse models.

Bosso G, Cintra Herpst A, Laguia O, Adetchessi S, Serrano R, Blasco M Cell Death Differ. 2024; 31(6):804-819.

PMID: 38698060 PMC: 11165013. DOI: 10.1038/s41418-024-01300-x.


NFAT1 and NFκB regulates expression of the common γ-chain cytokine receptor in activated T cells.

Shim J, Lee S, Jeong J, Kim H, Son W, Park J Cell Commun Signal. 2023; 21(1):309.

PMID: 37904191 PMC: 10617197. DOI: 10.1186/s12964-023-01326-7.


miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms.

Sewastianik T, Straubhaar J, Zhao J, Samur M, Adler K, Tanton H Blood. 2021; 137(14):1905-1919.

PMID: 33751108 PMC: 8033455. DOI: 10.1182/blood.2020009088.


Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation.

Becher L, Nevala W, Sutor S, Abergel M, Hoffmann M, Parks C Blood Adv. 2020; 4(21):5343-5356.

PMID: 33125463 PMC: 7656939. DOI: 10.1182/bloodadvances.2020002255.


Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and STAT6.

Jiang L, Zhao X, Mao Y, Wang J, Zheng H, You Q J Exp Clin Cancer Res. 2019; 38(1):465.

PMID: 31718693 PMC: 6852742. DOI: 10.1186/s13046-019-1428-0.


References
1.
Russell J, White C, Loh D . Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc Natl Acad Sci U S A. 1991; 88(6):2151-5. PMC: 51187. DOI: 10.1073/pnas.88.6.2151. View

2.
Moriggl R, Topham D, Teglund S, Sexl V, Mckay C, Wang D . Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity. 1999; 10(2):249-59. DOI: 10.1016/s1074-7613(00)80025-4. View

3.
Ju S, Panka D, Cui H, Ettinger R, El-Khatib M, Sherr D . Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 1995; 373(6513):444-8. DOI: 10.1038/373444a0. View

4.
Weinberg R . The retinoblastoma protein and cell cycle control. Cell. 1995; 81(3):323-30. DOI: 10.1016/0092-8674(95)90385-2. View

5.
Rieux-Laucat F, Le Deist F, Hivroz C, Roberts I, Debatin K, Fischer A . Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 1995; 268(5215):1347-9. DOI: 10.1126/science.7539157. View